LINK:

Phone number: 415-655-0003

Access Code: 2663 428 2506

Password: Lecture

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Describe the latest diagnostic pathways for Alzheimer's Disease and related dementias, including PET and blood based biomarkers. (2) Describe the principles of the latest standard of care therapies for Alzheimer's. (3) Apply these concepts in primary care to improve the care of your patients. 

FACULTY DISCLOSURE: John Bertelson MD, FAAN FASN, has financial interest in Eli Lilly and Eisai in the form of speaking.

PLANNER DISCLOSURE: Austin Metting, MD and Michael Volk, MD, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

*Recording of this educational activity, including the use of AI tools, is prohibited.

For information, please contact Aida Munoz-Murphy at [email protected]